Ignite Creation Date:
2024-05-06 @ 1:50 PM
Last Modification Date:
2024-10-26 @ 1:21 PM
Study NCT ID:
NCT04149574
Status:
TERMINATED
Last Update Posted:
2024-04-19
First Post:
2019-10-31
Brief Title:
A Study Comparing the Efficacy and Safety of Nivolumab in Combination With Bacillus Calmette-Guerin BCG Versus BCG Alone in Participants With High-Risk Non-Muscle Invasive Bladder Cancer HR NMIBC
Sponsor:
Organization:
Bristol-Myers Squibb
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
13
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE3 |
Observational Models:
Time Perspective List:
Who Masked List: